Skip to main content
Clinical Trials/NL-OMON49540
NL-OMON49540
Recruiting
Not Applicable

Study to Predict Inflammation and Neurodegeneration in Primary Progressive Multiple Sclerosis - SPIN-P

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
PPMS
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
350
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Aged 18 years or older
  • \- Diagnosis:
  • fulfills the 2017 McDonald criteria for PPMS
  • Strong clinical suspicion of PPMS that has not (yet) fulfilled the 2017
  • McDonald criteria (e.g. symptoms have not yet lasted a full year, and/or
  • dissemination in time and place have not yet been proven), but in which other
  • possible diagnoses have been excluded
  • \- Patients have to be able to give informed consent.

Exclusion Criteria

  • Severe comorbidity with a life expectancy of 6 months or less.

Outcomes

Primary Outcomes

Not specified

Similar Trials